Wikidata

(Q61906964)

English

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine

clinical trial

In more languages

Statements

short name
RVF (English)
0 references
title
A Phase 2 Open Label Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated, Dried, TSI-GSD 200, Lot 7, Run 2, in Adult Subjects at Risk of Exposure to Rift Valley Fever Virus (English)
0 references
medical condition
fever
0 references
coccidioidomycosis
0 references
coccidiosis
0 references
Rift Valley fever
0 references
start time
4 October 2018
0 references
end time
December 2023
0 references
number of participants
500
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61906964&oldid=2108035916"